You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 2, 2024

Claims for Patent: 10,010,260


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,010,260
Title:Methods for assessing and optimizing muscular performance including a stride rate tuning protocol
Abstract: A muscle assessment protocol can include: attaching one or more surface electromyometry (sEMG) sensors to the skin of a subject to be operably coupled with one or more muscles; operably coupling the one or more sEMG sensors to a computing system; performing the predetermined muscle activity of a muscle assessment protocol that includes a stride rate tuning protocol; monitoring/recording sEMG data of the one or more muscles during the predetermined muscle activity; and providing the sEMG data to the subject such that the subject can improve muscle performance for the predetermined muscle activity by using the sEMG data. The muscle activity includes static or dynamic muscle use. The predetermined muscle activity can be provided to the subject by the computing system.
Inventor(s): Grey; Alexander B (Campbell, CA), Georgiou; Violetta (Morgan Hill, CA), Belani; Abhishek (Los Altos Hills, CA)
Assignee: SOMAXIS INCORPORATED (San Jose, CA)
Application Number:14/795,005
Patent Claims:1. A muscle assessment protocol comprising: operably coupling one or more electromyometry (sEMG) sensors attached to skin of a subject to a computing system so as to be operably coupled with activity of one or more muscles of a subject while the subject performs a predetermined muscle activity of a muscle assessment protocol that includes a stride rate tuning protocol; monitoring and/or recording sEMG data of the one or more muscles during the predetermined muscle activity; and providing the sEMG data to the subject such that the subject can improve muscle performance for the predetermined muscle activity by using the sEMG data.

2. The muscle assessment protocol of claim 1, wherein the muscle activity includes static loading resistance or dynamic muscle use.

3. The muscle assessment protocol of claim 2, wherein the predetermined muscle activity is provided to the subject by the computing system.

4. The muscle assessment protocol of claim 3, wherein the predetermined muscle activity includes a continuous exercise routine and/or a noncontinuous exercise or routine.

5. The muscle assessment protocol of claim 4, wherein the continuous exercise routine includes one or more of walking, jogging, running, sprinting, hiking, cycling, rollerblading, roller skating, skiing, cross-country skiing, rowing, swimming, snowboarding, yoga, pilates, or the like.

6. The muscle assessment protocol of claim 4, wherein the noncontinuous exercise routine includes one or more of firing an arrow from a bow, weightlifting, golf swing, bat swing, ball throw, punch, kick, jumping, squatting, or the like.

7. The muscle assessment protocol of claim 4, wherein: in the stride rate tuning protocol the one or more sensors monitor muscle sEMG data while the subject adjusts their caloric consumption during a controlled activity based on sEMG data that is measured and/or analyzed, and the sEMG data is provided to the subject in order to facilitate the adjustment of caloric consumption.

8. The muscle assessment protocol of claim 4, wherein the sEMG data is a metric selected from: sEMG amplitude; instantaneous rectified sEMG amplitude; average rectified sEMG amplitude; area under sEMG curve; area over sEMG curve; integrated sEMG; derivative sEMG; frequency-based, amplitude adjusted RMS sEMG; mean power frequency (MPF); muscle fatigue onset index (MFOI); or a combination thereof.

9. The muscle assessment protocol of claim 1, further comprising: obtaining ECG data; and using the ECG data in conjunction with the sEMG data.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.